Adagio Therapeutics Relata Redução na Atividade Neutralizante In Vitro do ADG20 Contra a Variante Omicron SARS-CoV-2

Dados in vitro relatados anteriormente que demonstram que as mutações individuais do Omicron não estavam associadas à fuga de ADG20 não se confirmam nos ensaios autênticos de Omicron e de Pseudovírus WALTHAM, Mass., Dec. 14, 2021 (GLOBE NEWSWIRE) — A Adagio Therapeutics, Inc., (Nasdaq: ADGI) uma empresa biofarmacêutica de estágio clínico focada na descoberta, desenvolvimento […]

Merck Collaborates with Innovative Biotech to Support Establishment of First Vaccine Production Facility in Nigeria

– Supports West African pandemic readiness program – Accelerates self-sufficient vaccine development and manufacturing in West Africa LAGOS, Nigeria, Dec. 14, 2021 /PRNewswire/ — Merck, a leading science and technology company, today announced that it has signed an agreement with biotechnology company Innovative Biotech (IB) to design the manufacturing process for the first vaccine production […]